FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements

Welcome to NotebookCHECK - Notebook Forum.
Log in
Sign up

December 28, 2024, 09:46:24

News:

Willkommen im Notebookcheck.com Forum! Hier können sie über alle unsere Artikel und allgemein über Notebook relevante Dinge disuktieren. Viel Spass!

Main Menu

Home
Search

FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements

Started by Redaktion, February 12, 2022, 23:47:43

Previous topic - Next topic

Reply Print

Go Down Pages1

User actions

Redaktion

Editor
High End NB
Posts: 162,804
Logged

FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements

February 12, 2022, 23:47:43

Senseonics Holdings, Inc. has announced the FDA approval of its Eversense E3 CGM System. The company currently offers a 90-day capable continuous glucose monitor (CGM) but the Eversense E3 system will double that amount to 180 days. In addition, fewer fingerstick blood glucose measurements will be required.

https://www.notebookcheck.net/FDA-approves-Eversense-E3-6-month-continuous-glucose-monitor-that-requires-fewer-fingerstick-blood-glucose-measurements.599219.0.html

Reply Print

Go Up Pages1

User actions

Quick Reply

Warning: this topic has not been posted in for at least 120 days.
Unless you're sure you want to reply, please consider starting a new topic.

User actions

Reply Print